Indonesia’s Health Ministry Announces New Regulations on Online Pharmacy Sales
Table of Contents
the Indonesian Ministry of Health (Kementerian Kesehatan or Kemenkes) has issued new regulations, effective January 1, 2026, governing the online sale of prescription and over-the-counter medications, aiming to increase public safety and combat the proliferation of counterfeit drugs. These regulations significantly alter the landscape for both established pharmacies and emerging digital health platforms.
Regulation Details and Scope
The new regulations, outlined in Permenkes No. 68 of 2023, stipulate that only pharmacies holding valid Pharmacy Business Licenses (Izin Usaha Farmasi or IUF) can operate online pharmacies. This includes a requirement for a separate online pharmacy license, demonstrating compliance with specific technical and operational standards.
Detail: The regulations address several key areas, including prescription verification, drug storage and distribution, data privacy, and consumer protection. Online pharmacies must verify prescriptions electronically with prescribing doctors and maintain detailed records of all transactions.They are also required to ensure proper storage and transportation of medications to maintain their efficacy and safety.
Example: A key provision requires online pharmacies to utilize a centralized prescription database, integrated with the National Agency of Drug and Food control (BPOM), to prevent duplicate prescriptions and identify potential drug interactions.This system went live on a pilot basis in Jakarta in november 2025, processing over 50,000 prescriptions in it’s first month.
Requirements for Pharmacy Business Licenses (IUF)
To obtain an online pharmacy license, existing pharmacies must meet stringent criteria set by the Kemenkes.
Detail: These criteria include demonstrating a secure and reliable IT infrastructure, employing qualified pharmacists to oversee online operations, and implementing robust cybersecurity measures to protect patient data. Pharmacies must also adhere to Good Pharmacy Practice (GPP) standards in their online operations.
Example: The Kemenkes has mandated that all online pharmacies implement two-factor authentication for user accounts and encrypt all sensitive data, as detailed in a statement from the Ministry of Communication and Informatics on december 15, 2025. Failure to comply can result in license revocation.
Impact on digital Health Platforms
The new regulations significantly impact digital health platforms offering pharmacy services.
detail: Platforms that previously operated as intermediaries connecting patients with pharmacies are now required to either obtain their own pharmacy licenses or partner exclusively with licensed pharmacies. This has led to consolidation within the industry, with several smaller platforms being acquired by larger pharmacy chains.
Example: Halodoc, a leading Indonesian health-tech platform, announced a partnership with Kimia Farma, a state-owned pharmaceutical company, in october 2025, to ensure compliance with the new regulations. The Jakarta Post reported that this partnership involved Kimia Farma acquiring a 30% stake in Halodoc’s pharmacy division.
Enforcement and Penalties
The Kemenkes, in collaboration with the BPOM and the National Police, will actively enforce the new regulations.
Detail: Pharmacies operating without a valid online pharmacy license or violating the regulations face penalties ranging from fines to license revocation and criminal prosecution.The BPOM will conduct regular inspections of online pharmacies to ensure compliance.
Example: On January 8, 2026, the BPOM announced the closure of 15 illegal online pharmacies operating across Indonesia, seizing counterfeit medications worth an estimated IDR 5 billion (approximately USD $320,000).
